ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

September 7, 1990

In Brief: Senate Committee Cuts House Amount For NCI; NCI Staff Faces Up to 22 Days Unpaid Leave

September 21, 1990

Rauscher “Identifies” Four More Comprehensive Centers

June 21, 1974

Appeals Court Lifts Injunction On Federal Funding for Stem Cell Research.

September 10, 2010

Funding Opportunities Listed (12-page issue).

July 11, 2003

ORI Misconduct Findings Announced In Two Cases

July 12, 1996